Review
Recent trials of antioxidant therapy: What should we be telling our patients?
Bibi I. Hasnain, MD and Arshag D. Mooradian, MD
Cleveland Clinic Journal of Medicine April 2004, 71 (4) 327-334;
Bibi I. Hasnain
Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO
Arshag D. Mooradian
Division of Endocrinology, Diabetes, and Metabolism, Department of Internal Medicine, St. Louis University School of Medicine, St. Louis, MO

Article Information
vol. 71 no. 4 327-334
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online April 1, 2004.
Copyright & Usage
Copyright © 2004 The Cleveland Clinic Foundation. All Rights Reserved.
Cited By...
In this issue
Cleveland Clinic Journal of Medicine
Vol. 71, Issue 4
1 Apr 2004
Recent trials of antioxidant therapy: What should we be telling our patients?
Bibi I. Hasnain, Arshag D. Mooradian
Cleveland Clinic Journal of Medicine Apr 2004, 71 (4) 327-334;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Trending Cardiovascular Nutrition Controversies
- Adaptive Cellular Stress Pathways as Therapeutic Targets of Dietary Phytochemicals: Focus on the Nervous System
- Micronutrient concentrations and subclinical atherosclerosis in adults with HIV
- Effect of Cardiorespiratory Fitness on Vascular Regulation and Oxidative Stress in Postmenopausal Women
- NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities
- Antioxidant Vitamin Supplementation in Cardiovascular Diseases
- Some Dietary and Adipose Tissue Carotenoids Are Associated with the Risk of Nonfatal Acute Myocardial Infarction in Costa Rica
- Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in Hypertension: What Is the Clinical Significance?